02.14.19
Rodan & Fields' founders, Dr. Katie Rodan and Dr. Kathy Fields, have a new acne line -- and it is once again formulated with new patent-pending technology.
The new regimen is called Spotless, and it was developed for teens and young adults. It features a "BPO2 Technology," the company states, which leverages Benzoyl Peroxide in a groundbreaking new way.
Rodan + Fields has developed an innovative liquid form of Benzoyl Peroxide – an industry first – to get through the skin's stubborn biofilms, helping to bring the microbiome inside the pores back to balance and effectively combat the entire acne cycle.
"As practicing dermatologists, product developers and women, we understand the emotional, physical and scientific aspects of acne," said Dr. Katie Rodan, Co-Founder of Rodan + Fields. "Working side-by-side with our team of scientists and innovators we've pioneered many skincare firsts, and we're thrilled to have discovered a game-changing way to treat acne for teens," said Dr. Kathy Fields, Co-Founder of Rodan + Fields.
Acne can impact all ages, but adult skin requires a different approach. With that in mind, the company has updated its Unblemish Regimen, designed to address adult acne, as well as the visible signs of aging, with new formulas that feature Benzoyl Peroxide and Salicylic Acid.
"With our Founders' unique perspective and expertise, we believe these formulas will be a breakthrough in the category and give the overwhelming majority of consumers who experience acne an easy, at-home solution," said Diane Dietz, President and CEO of Rodan + Fields.
To celebrate the launch on February 21st, consumers purchasing the Spotless regimen receive the free purple backpack, shown above.